To the Editor, Carbamazepine is an effective anticonvulsant and has a relatively low incidence of adverse effects, although it occasionally causes hema- tologic disorders. We herein describe a patient with carbamazepine- induced thrombocytopenic purpura that was investigated by pharma- cological, immunological and genomic assays.
Carbamazepine-induced thrombocytopenic purpura in a child: Insights from a genomic analysis
ABATE, MARIA VALENTINA;STOCCO, GABRIELE;PIEROBON, CHIARA;LUCAFO, MARIANNA;DI SILVESTRE, ALESSIA;D'ADAMO, ADAMO PIO;Tommasini, Alberto;DECORTI, GIULIANA
;VENTURA, ALESSANDRO
2016-01-01
Abstract
To the Editor, Carbamazepine is an effective anticonvulsant and has a relatively low incidence of adverse effects, although it occasionally causes hema- tologic disorders. We herein describe a patient with carbamazepine- induced thrombocytopenic purpura that was investigated by pharma- cological, immunological and genomic assays.File in questo prodotto:
| File | Dimensione | Formato | |
|---|---|---|---|
|
carbamazepine.pdf
Accesso chiuso
Tipologia:
Documento in Versione Editoriale
Licenza:
Digital Rights Management non definito
Dimensione
1.51 MB
Formato
Adobe PDF
|
1.51 MB | Adobe PDF | Visualizza/Apri Richiedi una copia |
|
Manuscript.pdf
Open Access dal 02/08/2017
Tipologia:
Bozza finale post-referaggio (post-print)
Licenza:
Digital Rights Management non definito
Dimensione
114.97 kB
Formato
Adobe PDF
|
114.97 kB | Adobe PDF | Visualizza/Apri |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
